Target cell limited and immune control models of HIV infection: A comparison

被引:265
作者
De Boer, RJ
Perelson, AS
机构
[1] Univ Utrecht, NL-3584 CH Utrecht, Netherlands
[2] Univ Calif Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA
关键词
D O I
10.1006/jtbi.1997.0548
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We develop various mathematical models of the clinical latency stage of HIV-I infection assuming that HIV-1 infection is limited either by the availability of cells that HIV can infect or by a specific anti-HIV cellular immune response. The former models we call "target-cell-limited". Comparing the models by phase plane analysis we find that they all belong to the class of predator-prey models. In the target-cell-limited models the virus is a predator feeding upon target cell prey, while in the immune-control models the virus is a prey that is controlled by an immune response predator. Because both classes of models are of predator-prey type they behave similarly in most circumstances. We find that both types of model can account for the generic picture of disease progression in which the CD4 T cell count slowly decreases and the viral load slowly increases. Additionally, we find that both types of models can adequately describe the clinically observed changes in the plasma HIV-I RNA loads in response to retroviral therapies. (C) 1998 Academic Press Limited.
引用
收藏
页码:201 / 214
页数:14
相关论文
共 74 条
[1]   THE FALLACIES OF RATIO-DEPENDENT PREDATION [J].
ABRAMS, PA .
ECOLOGY, 1994, 75 (06) :1842-1850
[2]   Immunological memory and protective immunity: Understanding their relation [J].
Ahmed, R ;
Gray, D .
SCIENCE, 1996, 272 (5258) :54-60
[3]   EFFECTS OF CYCLOSPORIN ON T-CELL SUBSETS IN HUMAN IMMUNODEFICIENCY VIRUS-DISEASE [J].
ANDRIEU, JM ;
EVEN, P ;
VENET, A ;
TOURANI, JM ;
STERN, M ;
LOWENSTEIN, W ;
AUDROIN, C ;
EME, D ;
MASSON, D ;
SORS, H ;
ISRAELBIET, D ;
BELDJORD, K .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 47 (02) :181-198
[4]   SUSTAINED INCREASES IN CD4 CELL COUNTS IN ASYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-SEROPOSITIVE PATIENTS TREATED WITH PREDNISOLONE FOR 1 YEAR [J].
ANDRIEU, JM ;
LU, W ;
LEVY, R .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) :523-530
[5]  
Beddington J.R., 1975, J ANIM ECOL, V51, P597
[6]   Human immunodeficiency virus drug therapy and virus load [J].
Bonhoeffer, S ;
Coffin, JM ;
Nowak, MA .
JOURNAL OF VIROLOGY, 1997, 71 (04) :3275-3278
[7]   Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus [J].
Borrow, P ;
Lewicki, H ;
Wei, XP ;
Horwitz, MS ;
Peffer, N ;
Meyers, H ;
Nelson, JA ;
Gairin, JE ;
Hahn, BH ;
Oldstone, MBA ;
Shaw, GM .
NATURE MEDICINE, 1997, 3 (02) :205-211
[8]   ORDERED APPEARANCE OF ZIDOVUDINE RESISTANCE MUTATIONS DURING TREATMENT OF 18 HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE SUBJECTS [J].
BOUCHER, CAB ;
OSULLIVAN, E ;
MULDER, JW ;
RAMAUTARSING, C ;
KELLAM, P ;
DARBY, G ;
LANGE, JMA ;
GOUDSMIT, J ;
LARDER, BA .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (01) :105-110
[9]   Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine [J].
Brichacek, B ;
Swindells, S ;
Janoff, EN ;
Pirruccello, S ;
Stevenson, M .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) :1191-1199
[10]   QUIESCENT LYMPHOCYTES-T AS AN INDUCIBLE VIRUS RESERVOIR IN HIV-1 INFECTION [J].
BUKRINSKY, MI ;
STANWICK, TL ;
DEMPSEY, MP ;
STEVENSON, M .
SCIENCE, 1991, 254 (5030) :423-427